Pulmicort flexhaler and Dry mouth - a phase IV clinical study of FDA data

Summary:

Dry mouth is reported as a side effect among people who take Pulmicort flexhaler (budesonide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Symbicort, and have Gastrointestinal disorder.

The phase IV clinical study analyzes which people have Dry mouth when taking Pulmicort flexhaler. It is created by eHealthMe based on reports of 5,396 people who have side effects when taking Pulmicort flexhaler from the FDA, and is updated regularly.

What is Pulmicort flexhaler?

Pulmicort flexhaler has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 5,527 Pulmicort flexhaler users. Check the latest studies of Pulmicort flexhaler.

What is Dry mouth?

Dry mouth is found to be associated with 2,094 drugs and 2,492 conditions by eHealthMe. Check the latest studies of Dry mouth.

On Jul, 26, 2026

5,396 people reported to have side effects when taking Pulmicort flexhaler.
Among them, 47 people (0.87%) have Dry mouth.

Could Pulmicort flexhaler cause Dry mouth?

Among these 47 people:

How long have people been on Pulmicort flexhaler when they have Dry mouth? *

What is the gender of people who have Dry mouth when taking Pulmicort flexhaler? *

female: 76.09 %
male: 23.91 %

What is the age of people who have Dry mouth when taking Pulmicort flexhaler? *

What are other drugs people take besides Pulmicort flexhaler? *

What are other side effects people have besides Dry mouth? *

Cough: 11 people, 23.40%
Dyspnea (difficult or laboured breathing): 10 people, 21.28%
Hoarseness Or Changing Voice: 7 people, 14.89%
Stomatitis (inflammation of mucous membrane of mouth): 6 people, 12.77%
Drug Ineffective: 6 people, 12.77%
Taste - Impaired: 5 people, 10.64%
Wheezing (a high-pitched whistling sound made while you breath): 4 people, 8.51%
Memory Loss: 4 people, 8.51%
Nosebleed (bleeding from nose): 4 people, 8.51%
Weight Increased: 4 people, 8.51%

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 8.51%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 4 people, 8.51%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 4 people, 8.51%
Cough: 3 people, 6.38%
Depression: 3 people, 6.38%
Dyspnea (difficult or laboured breathing): 3 people, 6.38%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.38%
Hoarseness Or Changing Voice: 3 people, 6.38%
Irritable Bowel Syndrome: 2 people, 4.26%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 4.26%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort flexhaler and have Dry mouth?

- Check whether Dry mouth is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pulmicort flexhaler:

Pulmicort flexhaler (5,527 reports)

Dry mouth treatments and more:

Dry mouth (97,956 reports)

Browse all side effects of Pulmicort flexhaler:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dry mouth:

Dry mouth (2,094 drugs)

Browse all the conditions that are associated with Dry mouth:

Dry mouth (2,492 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Pulmicort flexhaler) and Pulmicort flexhaler (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.